News

World's first primary standard developed for molecular radiotherapy

The new primary standard for MRT
The new primary standard for MRT

Researchers from EMRP project develop the world's first primary standard for molecular radiotherapy (MRT) to treat cancer

The new standard will help improve the consistency of MRT treatments, in which radioactive molecules, or radiopharmaceuticals, are injected directly into a patient's body to target and kill cancerous cells. Such standardisation is vital to encourage more widespread use of MRT and develop new and improved radiopharmaceuticals.

Like any form of radiotherapy, the success of MRT relies on the delivery of an extremely precise dose of radiation. The goal is to maximise the dose delivered to the tumour, while minimising damage to surrounding healthy tissue. However, in contrast to other forms of radiotherapy, dosimetry for MRT is not well established. Researchers from EMRP project Metrology for molecular radiotherapy (HLT11 MetroMRT) developed the new standard.  A gas-filled ionisation chamber, containing two parallel electrodes an adjustable distance apart, enables the user to measure the absorbed radiation dose from a radioactive solution.

Select your area of interest
EMPIR project delivers new measurement systems for highly-parallel manufacturing
2018-11-22

Research enables order of magnitude improvements for European advanced manufacturing to quality-control tomorrow’s everyday devices more

Scientists are set to overhaul the International System of Units
2018-11-14

CGPM voting on SI redefinition on 16 November 2018 - kilogram set to be redefined more

World Science Day for peace and development
2018-11-10

Theme: Science, a human right more

EMPIR project publishes two ISO technical specifications
2018-11-06

Specifications fulfil demonstrated end user need more

Page 110 of 225.